For many practices, claim denials start as a nuisance and slowly evolve into a structural problem that erodes margins, staff morale, and strategic flexibility. Denials are not only a billing issue. They affect scheduling decisions, hiring plans, physician productivity, and even which service lines you can afford to grow.
Most organizations do not wake up one day with a “denials crisis.” The warning signs surface gradually in your aging reports, productivity metrics, and payer scorecards. By the time leadership recognizes the scale of the problem, a significant portion of avoidable write-offs has already been baked into the budget.
This article breaks down seven operational warning signs that your practice, group, or health system would benefit from dedicated denials management services. For each, you will see why it matters, how it impacts cash flow and operations, and what leaders should do next.
1. Your denial rate is stable, not improving, despite internal efforts
Every revenue cycle leader tracks denial rate, but the pattern over time is more important than the absolute number. Industry benchmarks vary by specialty and payer mix, but a net denial rate above roughly 5 to 8 percent is often considered a performance gap. The more concerning pattern is a denial rate that stays flat or worsens for six to twelve months despite initiatives such as staff education or new edits.
This usually indicates that your internal team is trapped in reactive work. Staff are spending the majority of their time resubmitting and appealing individual claims, rather than executing root cause correction at scale. Denials get “touched,” yet underlying drivers like authorization breakdowns, coding variability, or unstable payer rules remain unaddressed.
From a cash flow point of view, a flat or rising denial rate means you are normalizing leakage. Write-offs begin to be forecast as unavoidable. Physician leaders lose confidence in the billing function, which in turn complicates conversations about productivity goals and compensation.
Denials management services can change the operating model. Instead of treating denials as a downstream billing task, a dedicated partner typically brings:
- Denial classification frameworks that normalize payer CARC / RARC codes into a manageable set of operational categories.
- Closed loop root cause workflows that route issues back to registration, coding, authorization, or provider documentation with specific remediation steps.
- Trend analysis and payer performance reporting that leadership can actually act on, for example, contract language changes or escalations.
If your denial rate trend line has plateaued, leadership should ask three questions: Are we measuring denials with enough granularity to see patterns by payer, location, and denial type. Are we closing the feedback loop to upstream departments. And do we have the bandwidth and expertise to redesign workflows, not only fix claims. If any answer is no, external denials management support is likely warranted.
2. First-pass yield is lagging and staff are stuck in rework cycles
First-pass yield (also called first-pass resolution) is the percentage of claims that are accepted and paid without requiring correction or appeal. High-performing organizations often achieve > 90 percent first-pass yield for their commercial and Medicare book of business. If your practice is significantly below that range, or if your first-pass yield is volatile month to month, it is a clear sign that edits, coding, and pre-submission controls are not robust enough.
Low first-pass yield carries several operational consequences:
- Rework absorbs skilled staff time. Senior billers are pulled into repetitive correction work, rather than complex resolution and payer negotiations.
- Cash is delayed by multiple cycles. Each claim that requires resubmission or appeal can add 30 to 90 days to the time to collect, depending on payer and process design.
- Downstream metrics get distorted. Days in A/R, bad debt, and net collection rate are all impacted by the lag created by rework.
Denials management services approach this problem by attacking both front-end and mid-cycle failure points. A mature partner will typically:
- Map denial patterns into edit opportunities at your clearinghouse or practice management system.
- Align coding and charge capture rules with payer policies for high-risk services such as injections, imaging, and telehealth.
- Implement pre-submission quality checks, for example verifying that authorization numbers, COB details, and referring provider NPIs are present and valid.
Executives should monitor first-pass yield by payer, location, and service line, not only in aggregate. If the majority of your staff’s day is spent working “fix and resubmit” queues, then you are effectively paying twice for each dollar of cash. In that scenario, a specialist denials partner can often reduce rework volume by double digits within the first six to nine months, without adding headcount.
3. CARC / RARC codes are logged, not interpreted, and appeals success is low
Most billing teams can tell you which CARC or RARC codes are appearing most frequently on remits. Far fewer can explain how those codes translate into specific payer logic, contractual nuances, and documentation requirements. The distinction is critical. Logging denial reasons is not the same as interpreting them, and interpretation is what drives successful appeals and long-term prevention.
A common symptom is a low appeal success rate, or appeals that are limited to a small subset of denial types. Staff quietly abandon certain categories, for example medical necessity or experimental / investigational determinations, because they perceive them as “unwinnable.” Over time, your organization writes off a growing pool of claims that might have been recoverable with the right argument, documentation, and escalation path.
The financial impact is subtle but significant. If your team only appeals 20 to 30 percent of denials, and wins half of those, you are recovering a fraction of what might be collectible. You are also allowing payers to set precedent. If no one pushes back on particular edits or policies, those denials become normalized as the new baseline.
Denials management services bring depth in three areas that are difficult to cultivate internally:
- Payer-specific playbooks. Experienced partners maintain libraries of payer behaviors, appeal templates, and documentation strategies that have worked in similar cases.
- Clinical and coding expertise. For medical necessity or level-of-care denials, success often hinges on translating physician intent into language that aligns with coverage criteria.
- Structured appeal pipelines. Instead of ad hoc responses, appeals are triaged, prioritized by collectability, and escalated through formal payer channels.
Leaders should look at two simple KPIs: percentage of denials appealed, and appeal overturn rate by major payer and denial type. If either is low, and if your team treats certain denials as “automatic write-offs,” you likely need specialized denials management capabilities, either external or in a dedicated internal unit with proper tooling.
4. Front-end and mid-cycle teams are not aligned around denial prevention
Many organizations talk about “denials prevention,” but in practice, responsibilities are fragmented. Registration owns demographics and eligibility. Patient access handles authorizations. Clinicians and coders manage documentation and code assignment. The billing office works rejections and denials. If each department pursues its own local targets without a shared view of denial drivers, the same errors will recur.
Operationally, you will recognize this pattern if:
- The billing team frequently sends emails back to scheduling or registration about missing data, with no formal remediation plan.
- Coding and documentation queries spike after payer audits or specific batches of denials.
- Denial review meetings, if they happen, focus on “what went wrong last month,” not on redesigning workflows across departments.
From a financial standpoint, this misalignment leads to chronic leakage in several categories: eligibility and COB errors, authorization gaps, non-covered services billed without ABNs, and coding inconsistencies for high-visibility services. Each category looks small in isolation, but together they often represent a material percentage of net revenue.
Denials management services can function as the cross-functional glue that many organizations lack. A strong partner will:
- Convert denial data into process maps that show where in the lifecycle failures occur.
- Facilitate working sessions that involve registration, access, coding, and billing to redesign handoffs and standardize ownership.
- Build prevention checklists tied to top denial categories, for example “authorization sensitive services” or “COB high-risk patients.”
For leaders, the practical step is to treat denial prevention as a strategic initiative, not a side project of the billing team. That may mean dedicating a cross-functional steering group, assigning clear process owners for each major denial type, and measuring those owners on prevention metrics. If you do not have the bandwidth or internal analytics to support that structure, a denials management partner can accelerate the build-out while your team focuses on day-to-day operations.
5. Telehealth, high-cost drugs, and ancillary services are denied at higher rates
Denials are rarely distributed evenly across your charge mix. Emerging or complex service categories, such as telehealth, infusion drugs, imaging, or surgical ancillaries, often carry disproportionate denial risk. Payers update coverage policies and coding rules for these services more frequently than for routine office visits. If your organization lacks a formal governance process for such “policy sensitive” services, pockets of high denial rates can persist for months.
A few classic examples include:
- Telehealth visits billed with incorrect modifiers or place of service codes after payer policy changes.
- Specialty drugs administered in-office without proper authorization or documentation of step therapy failure.
- Pre- and post-operative services denied as inclusive or global because coding and sequencing rules were misapplied.
The revenue impact is magnified because these services carry higher unit reimbursement. Losing or delaying payment on infusion claims or surgical ancillaries can materially distort cash flow, even if the number of claims is relatively small compared with office visits.
Denials management services help by installing discipline around these high-risk categories. Typical interventions include:
- Service line specific denial dashboards that isolate performance for telehealth, infusion, imaging, or procedures, rather than burying them in aggregate metrics.
- Policy monitoring routines to track payer bulletins and translate them into coding, documentation, and authorization playbooks for your staff.
- Targeted training for providers and coders on documentation elements that support medical necessity and level-of-service determinations in these areas.
Executives should request denial and first-pass yield metrics at the CPT / HCPCS group level for high-value services. If those lines show significantly worse performance than the rest of the book of business, and if internal teams are struggling to keep up with policy changes, partnering with a denials-focused RCM vendor is often more cost effective than continuously retraining in-house staff.
6. Reporting is limited to static spreadsheets and cannot support decisions
Denials management is, at its core, an analytics challenge. You must be able to connect payer behavior, claim attributes, workflows, and outcomes over time. Many organizations still manage denial reporting primarily in static spreadsheets exported from the practice management system or clearinghouse. These files answer questions such as “How many denials did we have last month by payer.” They rarely answer questions like “Which three workflows, if fixed, would recover the most dollars over the next two quarters.”
Reporting limitations show up operationally as:
- Leadership meetings where the same topline denial numbers are reviewed monthly, without new insights or specific project charters.
- Inability to filter denials by provider, location, modality, or charge range to identify concentrated risk.
- No clear attribution of improvement, for example you implement an eligibility tool but cannot show its effect on related denial types.
Without decision grade analytics, teams default to anecdotal evidence. The loudest complaints, or the most visible payer, drive priorities instead of quantified opportunity. This leads to misallocation of effort and undermines executive confidence in revenue cycle initiatives.
Denials management services usually come with a data infrastructure that is difficult to replicate internally without dedicated BI resources. Capabilities often include:
- Denial dashboards that show denied dollars, avoidable vs non-avoidable categories, and aging in near real time.
- Drill down views to the claim and line level, enabling root cause analysis and targeted projects, for example “top 10 providers driving mod-25 denials.”
- Baseline and post-intervention tracking so you can quantify the ROI of specific prevention or appeal strategies.
For CFOs and RCM leaders, the governance question is simple. Can we, in one hour, identify the top three denial themes that, if fixed, would move our net collection by at least 1 to 2 percentage points over the next year. If the answer is no, and if building that capability in-house would take more than a year, partnering with a denials-focused vendor can compress that timeline significantly.
7. Staffing is stretched and denials work is chronically deprioritized
Even with good intent and decent tools, denials will remain unmanaged if staffing capacity and role design are misaligned. In many organizations, the same team that handles charge entry, payment posting, and refunds is also responsible for working denials. Under volume or staffing stress, denials are the first category to slip, because leaders prioritize current cycle work such as new charges and deposits.
Signs of structural understaffing or misalignment include:
- Denial worklists that grow faster than they are resolved, with items aging beyond payer filing limits.
- High turnover among experienced billers who feel they are “doing nothing but firefighting.”
- Inconsistent documentation of actions taken on denied claims, which undermines knowledge transfer and quality control.
The financial risk is clear. As denied claims age, collectability drops. Filing deadlines are missed. Small balance denials are written off because it is “not worth” the staff time to pursue them. Over time, these patterns create a structural drag on net revenue, which leadership often misattributes to payer behavior alone.
Denials management services offer two levers here:
- Dedicated capacity focused exclusively on denials, separated from day-to-day charge and payment workflows, which stabilizes throughput.
- Standardized work protocols including documentation templates, escalation criteria, and quality checks, which reduce variability when staff change.
Rather than viewing a denials partner as simply “extra hands,” executives should consider it a way to re-architect who does what. Internal staff can focus on high-value payer relationships, complex account resolution, and physician education. The partner can handle high-volume, rules-driven denial categories and maintain consistent queues. If your internal team never feels “caught up” on denials, and if you cannot justify adding permanent FTEs, a services engagement can be a scalable alternative.
Aligning denials management with your strategic revenue agenda
Unchecked denials are more than a billing inefficiency. They shape your ability to open new locations, recruit physicians, invest in technology, and negotiate payer contracts from a position of strength. When denial rates are high or stagnant, cash becomes unpredictable, and leadership spends more time reacting to shortfalls than planning growth.
Recognizing the warning signs early, and acting on them, gives your organization options. You can decide which denials to attack first, which workflows to redesign, and which capabilities to build versus buy. Denials management services are not a one size fits all solution, but they provide leverage in three critical domains: analytics, specialized expertise, and focused capacity.
If your leadership team is seeing stalled denial improvement, rising rework, incomplete reporting, or chronic staffing pressure, it is time to evaluate whether you have the internal foundation to reverse those trends at speed. If not, partnering with a dedicated denials management provider can help you stabilize cash flow, reduce preventable write-offs, and free your internal team to focus on strategic revenue initiatives.
To explore how a structured denials program could fit into your broader revenue cycle strategy, you can contact our team. A brief review of your current denial metrics and workflows is often enough to identify the top opportunities for fast, measurable improvement.
References
- Healthcare Financial Management Association. (n.d.). Key performance indicators for revenue cycle management. Retrieved from https://www.hfma.org
- Medical Group Management Association. (2022). MGMA data report: Optimizing the revenue cycle. Retrieved from https://www.mgma.com
- Change Healthcare. (2020). 2020 revenue cycle denials index. Retrieved from https://www.changehealthcare.com
